Cargando…
Opportunities and Challenges for the Development of MRCK Kinases Inhibitors as Potential Cancer Chemotherapeutics
Cytoskeleton organization and dynamics are rapidly regulated by post-translational modifications of key target proteins. Acting downstream of the Cdc42 GTPase, the myotonic dystrophy-related Cdc42-binding kinases MRCKα, MRCKβ, and MRCKγ have recently emerged as important players in cytoskeleton regu...
Autores principales: | Ruscetta, Vanessa M., Seaton, Taj J., Shakeel, Aleen, Vasconcelos, Stanley N. S., Viirre, Russell D., Adler, Marc J., Olson, Michael F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954052/ https://www.ncbi.nlm.nih.gov/pubmed/36831201 http://dx.doi.org/10.3390/cells12040534 |
Ejemplares similares
-
The actin-myosin regulatory MRCK kinases: regulation, biological functions and associations with human cancer
por: Unbekandt, Mathieu, et al.
Publicado: (2014) -
The CDC42 effector protein MRCKβ autophosphorylates on Threonine 1108
por: Unbekandt, Mathieu, et al.
Publicado: (2019) -
An Apical MRCK-driven Morphogenetic Pathway Controls Epithelial Polarity
por: Zihni, Ceniz, et al.
Publicado: (2017) -
A novel small-molecule MRCK inhibitor blocks cancer cell invasion
por: Unbekandt, Mathieu, et al.
Publicado: (2014) -
Co-Crystal Structures of Inhibitors with MRCKβ, a Key Regulator of Tumor Cell Invasion
por: Heikkila, Timo, et al.
Publicado: (2011)